Cytokinetics, Incorporated · NASDAQ:CYTK

Wierenga Wendell received 75 Cytokinetics, Incorporated shares as an award (Form 4)

Traded Jul 15, 2026 · Filed Jul 16, 2026

On Jul 15, 2026, Wierenga Wendell (Director) received 75 Cytokinetics, Incorporated shares as an award at US$82.62 for US$6,197, leaving 35,563 shares. Filed Jul 16, 2026 (Form 4).

Awarded
75 shares
Price
US$82.62
Value
US$6,197
Holding after
35,563 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 15, 2026Common StockAward75US$82.6235,563Direct

Source

View original at SEC

Related